Third Harmonic Bio Inc (THRD)

Apr 14, 2025, 6:45 AM EDT - 7 weeks ago

Third Harmonic Bio Announces Plan of Liquidation and Dissolution

Mar 27, 2025, 8:10 AM EDT - 2 months ago

Third Harmonic Bio Announces Fourth Quarter and Full Year 2024 Financial Results

Feb 12, 2025, 4:41 PM EST - 4 months ago

Third Harmonic Bio Initiates Strategic Review, Lays Off 50% Staff Citing Competitive Landscape

Feb 11, 2025, 7:00 AM EST - 4 months ago

Third Harmonic Bio Announces Phase 1 Clinical Results for THB335 and Provides Corporate Strategic Update

Nov 25, 2024, 4:00 PM EST - 6 months ago

Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference

Nov 7, 2024, 4:00 PM EST - 7 months ago

Third Harmonic Bio to Participate in Upcoming Investor Conferences in November

Nov 7, 2024, 8:10 AM EST - 7 months ago

Third Harmonic Bio Announces Third Quarter 2024 Financial Results

Sep 10, 2024, 4:00 PM EDT - 9 months ago

Third Harmonic Bio to Participate in Upcoming Investor Conferences in September

Aug 26, 2024, 4:00 PM EDT - 10 months ago

Third Harmonic Bio to Participate in Upcoming Investor Conferences

Aug 8, 2024, 8:05 AM EDT - 10 months ago

Third Harmonic Bio Announces Second Quarter 2024 Financial Results and Provides Business Update

May 28, 2024, 4:05 PM EDT - 1 year ago

Third Harmonic Bio to Participate in the Jefferies Global Healthcare Conference

May 15, 2024, 8:05 AM EDT - 1 year ago

Third Harmonic Bio Announces First Quarter 2024 Financial Results and Provides Business Update

Mar 28, 2024, 8:30 AM EDT - 1 year ago

Third Harmonic Bio Appoints Geoff McDonough, M.D., to its Board of Directors

Mar 26, 2024, 8:05 AM EDT - 1 year ago

Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results

Feb 26, 2024, 4:00 PM EST - 1 year ago

Third Harmonic Bio to Participate in the 44th Annual TD Cowen Health Care Conference

Jan 4, 2024, 8:00 AM EST - 1 year ago

Third Harmonic Bio Appoints Christopher Murphy as Chief Financial and Business Officer and Provides Business Update

Nov 9, 2023, 8:30 AM EST - 1 year ago

Third Harmonic Bio Announces Third Quarter 2023 Financial Results

Oct 31, 2023, 8:30 AM EDT - 1 year ago

Third Harmonic Bio Announces Leadership Changes

Aug 31, 2023, 8:30 AM EDT - 1 year ago

Third Harmonic Bio to Participate in the Morgan Stanley Global Healthcare Conference

Aug 10, 2023, 8:10 AM EDT - 1 year ago

Third Harmonic Bio Announces Second Quarter 2023 Financial Results

Jul 25, 2023, 8:30 AM EDT - 2 years ago

Third Harmonic Bio Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335

May 11, 2023, 5:00 PM EDT - 2 years ago

Third Harmonic Bio Announces First Quarter 2023 Financial Results

Mar 29, 2023, 8:05 AM EDT - 2 years ago

Third Harmonic Bio Announces Fourth Quarter and Year-End 2022 Financial Results

Feb 3, 2023, 1:35 PM EST - 2 years ago

Top 5 Health Care Stocks That May Rally - AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN)

AMGN AZN PFE

Jan 27, 2023, 8:48 AM EST - 2 years ago

5 Cheapest Health Care Stocks You Should Think About

ABBV FATE TECH

Jan 13, 2023, 8:45 AM EST - 2 years ago

5 Cheapest Health Care Stocks You Should Think About - Baxter Intl (NYSE:BAX), Cutera (NASDAQ:CUTR)

BAX VERA

Jan 10, 2023, 7:33 AM EST - 2 years ago

Top 5 Health Care Stocks That May Surge - Graphite Bio (NASDAQ:GRPH), Fate Therapeutics (NASDAQ:FATE)

FATE IPSC VERA

Dec 15, 2022, 8:22 AM EST - 2 years ago

Third Harmonic's stock falls 75% after discontinuing clinical trial

Dec 15, 2022, 7:00 AM EST - 2 years ago

Third Harmonic Bio Announces Discontinuation of Phase 1b Study of THB001 in Chronic Inducible Urticaria

Nov 21, 2022, 4:05 PM EST - 2 years ago

Third Harmonic Bio to Participate in Fireside Chat at the Evercore ISI 5th Annual HealthCONx Conference

Nov 9, 2022, 4:15 PM EST - 2 years ago

Third Harmonic Bio Announces Third Quarter 2022 Financial Results and Provides Corporate Update

Sep 21, 2022, 5:54 PM EDT - 2 years ago

Third Harmonic Scores Most Successful Biotech IPO in Months

Sep 19, 2022, 4:10 PM EDT - 2 years ago

Third Harmonic Bio Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares

Sep 15, 2022, 11:41 AM EDT - 2 years ago

Third Harmonic Bio stock opens more than 20% above IPO price

Sep 15, 2022, 7:58 AM EDT - 2 years ago

Third Harmonic Bio prices upsized IPO at $17 a share, midpoint of range

Sep 14, 2022, 7:33 PM EDT - 2 years ago

Third Harmonic Bio Announces Pricing of Upsized Initial Public Offering